178 related articles for article (PubMed ID: 19095021)
1. Complexation hydrogels for intestinal delivery of interferon beta and calcitonin.
Kamei N; Morishita M; Chiba H; Kavimandan NJ; Peppas NA; Takayama K
J Control Release; 2009 Mar; 134(2):98-102. PubMed ID: 19095021
[TBL] [Abstract][Full Text] [Related]
2. Combination Strategy with Complexation Hydrogels and Cell-Penetrating Peptides for Oral Delivery of Insulin.
Fukuoka Y; Khafagy ES; Goto T; Kamei N; Takayama K; Peppas NA; Takeda-Morishita M
Biol Pharm Bull; 2018; 41(5):811-814. PubMed ID: 29709919
[TBL] [Abstract][Full Text] [Related]
3. Complexation hydrogels for oral insulin delivery: effects of polymer dosing on in vivo efficacy.
Tuesca A; Nakamura K; Morishita M; Joseph J; Peppas N; Lowman A
J Pharm Sci; 2008 Jul; 97(7):2607-18. PubMed ID: 17876768
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal transit and mucoadhesive characteristics of complexation hydrogels in rats.
Goto T; Morishita M; Kavimandan NJ; Takayama K; Peppas NA
J Pharm Sci; 2006 Feb; 95(2):462-9. PubMed ID: 16381013
[TBL] [Abstract][Full Text] [Related]
5. Wheat germ agglutinin functionalized complexation hydrogels for oral insulin delivery.
Wood KM; Stone GM; Peppas NA
Biomacromolecules; 2008 Apr; 9(4):1293-8. PubMed ID: 18330990
[TBL] [Abstract][Full Text] [Related]
6. Design of pH-Responsive Biomaterials to Enable the Oral Route of Hematological Factor IX.
Horava SD; Peppas NA
Ann Biomed Eng; 2016 Jun; 44(6):1970-82. PubMed ID: 26883955
[TBL] [Abstract][Full Text] [Related]
7. Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics.
Nakamura K; Murray RJ; Joseph JI; Peppas NA; Morishita M; Lowman AM
J Control Release; 2004 Mar; 95(3):589-99. PubMed ID: 15023469
[TBL] [Abstract][Full Text] [Related]
8. Release behaviour and biocompatibility of drug-loaded pH sensitive particles.
Sipahigil O; Gürsoy A; Cakalağaoğlu F; Okar I
Int J Pharm; 2006 Mar; 311(1-2):130-8. PubMed ID: 16427223
[TBL] [Abstract][Full Text] [Related]
9. PEGylated insulin loaded complexation hydrogels for protected oral delivery.
Coolich MK; Lanier OL; Cisneros E; Peppas NA
J Control Release; 2023 Dec; 364():216-226. PubMed ID: 37890591
[TBL] [Abstract][Full Text] [Related]
10. Complexation graft copolymer networks: swelling properties, calcium binding and proteolytic enzyme inhibition.
Madsen F; Peppas NA
Biomaterials; 1999 Sep; 20(18):1701-8. PubMed ID: 10503971
[TBL] [Abstract][Full Text] [Related]
11. Complexation hydrogels for oral protein delivery: an in vitro assessment of the insulin transport-enhancing effects following dissolution in simulated digestive fluids.
Perakslis E; Tuesca A; Lowman A
J Biomater Sci Polym Ed; 2007; 18(12):1475-90. PubMed ID: 17988515
[TBL] [Abstract][Full Text] [Related]
12. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery.
Kumar A; Lahiri SS; Singh H
Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246
[TBL] [Abstract][Full Text] [Related]
13. Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats.
Morishita M; Goto T; Nakamura K; Lowman AM; Takayama K; Peppas NA
J Control Release; 2006 Feb; 110(3):587-94. PubMed ID: 16325951
[TBL] [Abstract][Full Text] [Related]
14. pH-responsive and enzymatically-responsive hydrogel microparticles for the oral delivery of therapeutic proteins: Effects of protein size, crosslinking density, and hydrogel degradation on protein delivery.
Koetting MC; Guido JF; Gupta M; Zhang A; Peppas NA
J Control Release; 2016 Jan; 221():18-25. PubMed ID: 26616761
[TBL] [Abstract][Full Text] [Related]
15. Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption.
Morishita M; Goto T; Peppas NA; Joseph JI; Torjman MC; Munsick C; Nakamura K; Yamagata T; Takayama K; Lowman AM
J Control Release; 2004 May; 97(1):115-24. PubMed ID: 15147809
[TBL] [Abstract][Full Text] [Related]
16. Student Award for Outstanding Research Winner in the Undergraduate Category for the 2017 Society for Biomaterials Annual Meeting and Exposition, April 5-8, 2017, Minneapolis, Minnesota: Development and characterization of stimuli-responsive hydrogel microcarriers for oral protein delivery.
O'Connor C; Steichen S; Peppas NA
J Biomed Mater Res A; 2017 May; 105(5):1243-1251. PubMed ID: 28177593
[TBL] [Abstract][Full Text] [Related]
17. In vitro release behavior and stability of insulin in complexation hydrogels as oral drug delivery carriers.
Kim B; Peppas NA
Int J Pharm; 2003 Nov; 266(1-2):29-37. PubMed ID: 14559391
[TBL] [Abstract][Full Text] [Related]
18. Loading and mobility of spin-labeled insulin in physiologically responsive complexation hydrogels intended for oral administration.
Besheer A; Wood KM; Peppas NA; Mäder K
J Control Release; 2006 Mar; 111(1-2):73-80. PubMed ID: 16460830
[TBL] [Abstract][Full Text] [Related]
19. Novel complexation hydrogels for oral peptide delivery: in vitro evaluation of their cytocompatibility and insulin-transport enhancing effects using Caco-2 cell monolayers.
Ichikawa H; Peppas NA
J Biomed Mater Res A; 2003 Nov; 67(2):609-17. PubMed ID: 14566804
[TBL] [Abstract][Full Text] [Related]
20. Acute oral toxicity evaluation of biodegradable and pH-sensitive hydrogel based on polycaprolactone, poly(ethylene glycol) and methylacrylic acid (MAA).
Chen X; Qian Z; Gou M; Chao G; Zhang Y; Gu Y; Huang M; Wang J; Pan Y; Wei Y; Chen J; Tu M
J Biomed Mater Res A; 2008 Mar; 84(3):589-97. PubMed ID: 17618490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
